ScholarIQanswers from OpenAlex

A phase II trial of huperzine A in mild to moderate Alzheimer disease

PaperCitations, authors & open-access status

A phase II trial of huperzine A in mild to moderate Alzheimer disease is a paper indexed in ScholarIQ from OpenAlex.

How many citations does A phase II trial of huperzine A in mild to moderate Alzheimer disease have?

ScholarIQcitation count

A phase II trial of huperzine A in mild to moderate Alzheimer disease has 236 citations in the OpenAlex counts ScholarIQ stores.

When was A phase II trial of huperzine A in mild to moderate Alzheimer disease published?

ScholarIQyear

A phase II trial of huperzine A in mild to moderate Alzheimer disease has 2011 year in the ScholarIQ index.

What is the open-access status of A phase II trial of huperzine A in mild to moderate Alzheimer disease?

ScholarIQoa status

A phase II trial of huperzine A in mild to moderate Alzheimer disease has bronze oa status in the ScholarIQ index.

What is the DOI of A phase II trial of huperzine A in mild to moderate Alzheimer disease?

ScholarIQdoi

The DOI for A phase II trial of huperzine A in mild to moderate Alzheimer disease is on the source record.

What is the PMID of A phase II trial of huperzine A in mild to moderate Alzheimer disease?

ScholarIQpmid

The PMID for A phase II trial of huperzine A in mild to moderate Alzheimer disease is on the source record.

What is the OpenAlex record for A phase II trial of huperzine A in mild to moderate Alzheimer disease?

ScholarIQopenalex

The OpenAlex for A phase II trial of huperzine A in mild to moderate Alzheimer disease is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial